Make the shift to non-invasive biomarker discovery.

Tymora Analytical is an innovative R&D laboratory specializing in non-invasive biomarker discovery to better understand and diagnose diseases such as cancer and Alzheimer’s.


Contact us

Shift from standard to biopsy-free.

Our research leads to biopsy-free diagnosis, which is less invasive and more comprehensive than standard biopsies.


Learn More

Detect active cancer proteins.

Our EVtrap method allows us to focus on proteins and phosphoproteins that indicate what’s really going on with disease.


Learn More

Better biomarker discovery from liquid biopsy.

Our services aid in the discovery of proteins and phosphoproteins from plasma, urine or saliva, allowing you to find and validate better biomarkers.


Learn More

Learn more about pIMAGO.

pIMAGO is a non-antibody method for unbiased universal detection of protein phosphorylation.

Watch an introductory video about pIMAGO.


Learn More

Introducing One-Step PolyMAC phosphopeptide enrichment.


Learn More

Learn more about our EVtrap technology.

EVtrap lets us help other researchers detect active cancer proteins and phosphoproteins with non-invasive liquid biopsies.


Learn More

Contact us.

Whether you’re a research scientist or a pharmaceutical company, you can contact Tymora Analytical for more information or collaboration opportunities.

Learn about us.

We provide biofluid analysis services, products like pIMAGO and PolyMac, and more. We’d love to share our products, services, and technology with you!

Partner with us.

Our team has discovered a way to analyze s so we can help others detect cancer and other diseases. You can collaborate with us for future discoveries.

Here’s a better way to analyze EV (exosome) proteins and PTMs.

We’ve developed an improved approach to analyze EV (exosome) proteins, phosphoproteins and other cancer-signaling molecules.


This technology, based on non-antibody affinity beads, is EVtrap (Extracellular Vesicles Total Recovery and Purification) to help others learn more about cancer and other diseases.

Tymora Analytical routinely identifies over 1,000 unique proteins from EVs from only 10uL of plasma or 0.2mL of urine, a significant improvement over any prior data.

Tymora Analytical routinely identifies over 1,000 phosphoproteins from EVs from only 1mL of plasma or 10mL of urine, a significant improvement over any prior data.

Technology Summary and Value Proposition

Why is non-invasive biomarker discovery superior to genetic analysis? Download our Technology Summary and Value Proposition to find out.

 

Download Now

Who should partner with Tymora?

Contract Research Organizations (CROs)

If you conduct research for pharmaceutical, biotechnology, or medical device companies—with us, you can deliver innovative research and help them save costs on biomarker discovery and drug development.

Pharmaceutical and Biotechnology Companies

If you work in pharmaceuticals or biotechnology, you can study biofluid samples with our non-invasive biomarker discovery to develop a companion diagnostic for your therapy.

Research Scientists and Clinical Program Directors

If your career involves researching for cures or overseeing a research team, you can partner with Tymora Analytical to gain access to more effective, state-of-the-art technologies.


Why partner with Tymora Analytical?

Whether you’re researching biomarkers or developing a new drug, we understand how important your work is. That’s why we’ve developed a more effective way for you to analyze and develop new disease markers.

Currently, genetic screens dominate the market. However, genes just show one’s predisposition to developing a disease— for example, a 40% chance of getting breast cancer. In addition, CTCs and cfDNA are present at very low levels and are extremely difficult to detect at early stages.

Non-invasive protein analysis, on the other hand, provides real-time information about one’s disease progression. Tymora Analytical conducts this biopsy-free test using exosomes and other EVs so we can analyze what’s actually going on.

We’ve developed a new technology—EVtrap—to help other researchers detect thousands of active disease proteins and phosphoproteins from biofluids like blood, urine, and saliva. And, we would love to collaborate with you for more biomarker discoveries.

When you work with us, you’re getting:


  • Innovative R&D products and services 
  • Unprecedented technology like EVtrap
  • Accurate information about a disease’s progression
  • Grant assistance for funding your research 
  • Helpful resources for ongoing education

Reach out to us at Tymora Analytical.

Call us at (765) 490-6834, or visit us at 3495 Kent Ave., Suite E400 in West Lafayette, Indiana. You can also email us or fill out our contact form.

Learn about our products and services.

You can conduct services like blood, urine, and saliva tests with our non-invasive biomarker discovery approach. Unlike tissue biopsies, these procedures also have a low rejection/failure rate.

Partner with us for innovative research.

With Tymora Analytical you’ll conduct groundbreaking research and detect cancer-relevant signaling marker proteins. You can help us advance life sciences and save lives!

Want to learn more about our plasma proteome/PTMs analysis?


Contact us